Clovis Investor Sues In Chancery Over Cancer Drug Trials
An investor in Clovis Oncology Inc. has launched a derivative lawsuit in the Delaware Chancery Court accusing the company board of breaches connected to the clinical trials of the firm's showcase...To view the full article, register now.
Already a subscriber? Click here to view full article